Back
Cardinal Health 10K Form
Sell
50
CAH
Cardinal Health
Last Price:
122.88
Seasonality Move:
6.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | CAH/Cardinal Health Quarterly |
| 2024-02-01 | 10Q | CAH/Cardinal Health Quarterly |
| 2023-11-03 | 10Q | CAH/Cardinal Health Quarterly |
| 2023-08-15 | 10K | CAH/Cardinal Health Annual |
| 2023-05-04 | 10Q | CAH/Cardinal Health Quarterly |
| 2023-02-02 | 10Q | CAH/Cardinal Health Quarterly |
Receive CAH News And Ratings
See the #1 stock for the next 7 days that we like better than CAH
CAH Financial Statistics
Sales & Book Value
| Annual Sales: | $226.83B |
|---|---|
| Cash Flow: | $-1.74B |
| Price / Cash Flow: | 27.92 |
| Annual Sales: | $-13.55 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 5.14000 |
|---|---|
| Net Income (TTM): | $1.26B |
| Gross Margin: | $7.41B |
| Return on Equity: | 0% |
| Return on Assets: | 2.82% |
Cardinal Health Earnings Forecast
Key Cardinal Health Financial Ratios
- The Gross Profit Margin over the past 41 years for CAH is 3.27%.
- The Selling, General & Administrative Expenses for CAH have been equal to 2.20% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 5.99% of Operating Income.
- The Net Earning history of CAH is 0.38% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 26 years.
Cardinal Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | CAH |
| CUSIP: | 14149Y |
| Website: | cardinalhealth.com |
Debt
| Debt-to-Equity Ratio: | -1.58 |
|---|---|
| Current Ratio: | 0.95 |
| Quick Ratio: | 0.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 35.5 |
|---|---|
| Forward P/E Ratio: | 14.16 |
CAH Technical Analysis vs Fundamental Analysis
Sell
50
Cardinal Health (CAH)
is a Sell
Is Cardinal Health a Buy or a Sell?
-
Cardinal Health stock is rated a Sell
The current Cardinal Health [CAH] share price is $122.47. The Score for CAH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.